Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

GlaxoSmithKline Pharmaceuticals Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

16 May 2015 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - GLAXOSMITHKLINE PHARMACEUTICALS LIMITED (GLAXO-IN)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

20 May 2015 Thomson Reuters Stock Report 11 $25.00

Wright Investors Service Comprehensive Report for Glaxosmithkline Pharmaceuticals Limited

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

26 Apr 2015 Wright Reports 56 $75.00

GlaxoSmithKline Pharmaceuticals Limited (GLAXO) - Financial and Strategic SWOT Analysis Review

GlaxoSmithKline Pharmaceuticals Limited (GLAXO) - Financial and Strategic SWOT Analysis Review Summary GlaxoSmithKline Pharma...

08 Apr 2015 GlobalData 43 $125.00

MOSL: GSK PHARMA (Neutral) - Sharp revenue miss drags 4Q performance

GSK PHARMA 4QCY14: Sharp revenue miss drags 4Q performance (GLXO IN, Mkt Cap USD4.5b, CMP INR3254, TP INR3300, 1% Upside, Ne...

13 Feb 2015 Motilal Oswal Securities Ltd. 10 $104.00

GlaxoSmithkline Pharma (GLXO) - Qtr. Update - Dated - February 12, 2015

GSK Pharma (GLXO IN; HOLD; TP – Rs 2,970; 9% downside from CMP of Rs 3,254). GSK Pharma’s Q4CY14 adj. PAT (Rs 941 mn, dow...

13 Feb 2015 Axis Capital Limited 5 $46.00

GlaxoSmithKline Pharmaceuticals Limited (GLAXO) - Financial and Strategic SWOT Analysis Review

GlaxoSmithKline Pharmaceuticals Limited (GLAXO) - Financial and Strategic SWOT Analysis Review Summary GlaxoSmithKline Pharma...

07 Jan 2015 GlobalData 41 $125.00

MOSL : GLAXO PHARMA (Neutral) - Results above estimate, recovery in earnings growth well priced in

GLAXO PHARMA 3QCY14: Results above estimate, recovery in earnings growth well priced in (GLXO IN, Mkt Cap USD3.8b, CMP INR27...

10 Nov 2014 Motilal Oswal Securities Ltd. 6 $58.00

GlaxoSmithKline Pharmaceuticals Limited (GLAXO) - Financial and Strategic SWOT Analysis Review

GlaxoSmithKline Pharmaceuticals Limited (GLAXO) - Financial and Strategic SWOT Analysis Review Summary GlaxoSmithKline Pharma...

07 Nov 2014 GlobalData 44 $125.00

GlaxoSmithkline Pharma (GLXO) - Qtr. Update - Dated - November 06, 2014

GSK Pharma’s (Bloomberg: GLXO IN) Q3CY14 performance was significantly ahead of expectations led by 19% YoY growth in revenue...

07 Nov 2014 Axis Capital Limited 4 $35.00